The Massachusetts General Hospital Guide to Depression
Springer International Publishing (Verlag)
978-3-030-07323-7 (ISBN)
Major Depressive Disorder (MDD) is one of the most prevalent psychiatric disorders, with a lifetime prevalence rate of roughly 20%. MDD is a leading cause of disability and premature death worldwide, leads to greater impairment in work functioning than other chronic medical conditions, and has an estimated annual cost of $210 billion in the US.
The proposed text is designed for mental health professionals and will present state-of-the-art treatment options that are used in the Depression Clinical and Research Program (DCRP) at the Massachusetts General Hospital. The text provides different treatment options so that providers can 'think outside the box' of conventional interventions. The introductory sections discuss general themes about diagnosing and treating depression. The major body of the book, however, consists of chapters organized under the topics of new medication, new psychotherapy, alternative treatments, and consideration of specific populations and how to modify interventions to best treat these patients. Each chapter begins with a case vignette to illustrate key characteristics of the disorder process or treatment and reviews the history, research support, and new advances of these topics. In addition, the chapters include a description of how to apply this topic in treatment and frequently asked questions and answers.
This book will be a unique contribution to the field. Existing guides focus on individual treatments of Depression, or include brief descriptions of interventions as a whole. The DCRP has consistently been a forerunner of clinical treatments for depression and often treats challenging cases of this disorder. This book will provide a practical and useful resource with wide applicability.
Benjamin G. Shapero, Ph.D. Assistant in Psychology, Department of Psychiatry, Massachusetts General Hospital Member of Faculty of Psychiatry, Harvard Medical School 1 Bowdoin Square, 6th Floor Boston, MA 02114David Mischoulon, M.D. Ph.D. Director, Depression Clinical and Research Program, Massachusetts General Hospital Associate Professor of Psychiatry, Harvard Medical School 1 Bowdoin Square, 6th Floor Boston, MA 02114 Cristina Cusin, M.D. Director, Translational Studies in the Depression Clinical and Research Program, Massachusetts General Hospital Assistant Professor of Psychiatry, Harvard Medical School 1 Bowdoin Square, 6th Floor Boston, MA 02114 David Mischoulon is an Associate Psychiatrist at Massachusetts General Hospital, an Associate Professor of Psychiatry at Harvard Medical School, and the Director of Research and Alternative Remedy Studies at the Depression Clinical and Research Program at Massachusetts General Hospital. Dr. Mischoulon graduated from the combined MD-PhD program at Boston University School of Medicine in 1994, and then interned in preliminary medicine at Carney Hospital from 1994-1995. From 1995-1998 he completed his residency in adult psychiatry at Massachusetts General Hospital, where he served as Chief Resident in Psychopharmacology. Dr. Mischoulon has authored or co-authored more than 100original articles, review articles, and book chapters, and has also co-edited a textbook on natural medications for psychiatric disorders.
Treatment-Resistant Depression.- Co-Occurring MDD and Problematic Alcohol Use.- Depression and Chronic Medical Illness: New Treatment Approaches.- Culture and Depression: Clinical Considerations for Racial and Ethnic Minorities.- Early Onset of Depression During Childhood and Adolescence.- Cross-Cultural Approaches to Mental Health Challenges Among Students.- Depression After Traumatic Brain Injury.- Personalized Medicine.- Depression, Antidepressants, and Sexual Functioning.- Ketamine as a Rapid Antidepressant.- Neuroactive Steroids and Depression.- Unified Protocol for Treatment of Depression.- Mindfulness Based Cognitive Therapy.- The Role of Technology in the Treatment of Depression.- Supplements and Natural Remedies for Depression.- The Effects of Tai Chi and Qigong on Anxiety and Depression.- Yoga as a Treatment for Depression.- Photobiomodulation.
"This guide presents the most up-to-date, cutting-edge pharmacological, non-pharmacological, somatic treatments and psychotherapeutic interventions for patients struggling with difficult-to-treat depression. ... The strength of this book lies in the chapters describing more novel treatments, which even the most seasoned psychiatrists are not necessarily familiar with. This book will be of great use to clinicians at all levels of experience." (Michael Easton, Doody's Book Reviews, April, 2019)
“This guide presents the most up-to-date, cutting-edge pharmacological, non-pharmacological, somatic treatments and psychotherapeutic interventions for patients struggling with difficult-to-treat depression. … The strength of this book lies in the chapters describing more novel treatments, which even the most seasoned psychiatrists are not necessarily familiar with. This book will be of great use to clinicians at all levels of experience.” (Michael Easton, Doody's Book Reviews, April, 2019)
| Erscheinungsdatum | 23.06.2023 |
|---|---|
| Reihe/Serie | Current Clinical Psychiatry |
| Zusatzinfo | XXV, 255 p. 6 illus., 4 illus. in color. |
| Verlagsort | Cham |
| Sprache | englisch |
| Maße | 210 x 279 mm |
| Gewicht | 1003 g |
| Themenwelt | Geisteswissenschaften ► Psychologie ► Klinische Psychologie |
| Medizin / Pharmazie ► Gesundheitswesen | |
| Medizin / Pharmazie ► Medizinische Fachgebiete ► Psychiatrie / Psychotherapie | |
| Schlagworte | Depression and medical comorbidities • Depression in special populations • Major Depression Disorder (MDD) • Non-pharmacological treatments of depression • pharmacotherapy • Treatment-resistant depression |
| ISBN-10 | 3-030-07323-8 / 3030073238 |
| ISBN-13 | 978-3-030-07323-7 / 9783030073237 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
aus dem Bereich
